HB1380 (2024) Detail

(New Title) relative to brew pub licenses, relative to insurance cost-sharing calculations, and relative to receipt of pharmaceutical rebates by insurers and pharmacy benefits managers.


HB 1380-FN - AS AMENDED BY THE SENATE

 

28Mar2024... 0872h

05/15/2024   1826s

05/23/2024   2119s

 

2024 SESSION

24-2339

08/05

 

HOUSE BILL 1380-FN

 

AN ACT relative to brew pub licenses, relative to insurance cost-sharing calculations, and relative to receipt of pharmaceutical rebates by insurers and pharmacy benefits managers.

 

SPONSORS: Rep. Hunt, Ches. 14

 

COMMITTEE: Commerce and Consumer Affairs

 

─────────────────────────────────────────────────────────────────

 

AMENDED ANALYSIS

 

This bill:

 

I.  Allows a brew pub licensee to also hold an on-premises or off-premises license.

 

II.  Provides that, when calculating an enrollee's contribution to cost-sharing requirements, the insurer or pharmacy benefits manager shall include any amount paid by the enrollee or paid on their behalf.  

 

III.  Includes a limited exception for health savings account-qualified high deductible health plans if application of the requirement would result in account ineligibility under the Internal Revenue Code.

 

IV.  Revises the annual reporting requirement for pharmacy benefits managers regarding pharmaceutical rebates.  

 

V.  Revises the percentage of rebates insurers are required to make available to enrollees, increases the fine for noncompliance, and removes prospective repeal of RSA 415-A:7, relative to insurer cost sharing of rebates.

 

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

 

Explanation: Matter added to current law appears in bold italics.

Matter removed from current law appears [in brackets and struckthrough.]

Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.

28Mar2024... 0872h

05/15/2024   1826s

05/23/2024   2119s 24-2339

08/05

 

STATE OF NEW HAMPSHIRE

 

In the Year of Our Lord Two Thousand Twenty Four

 

AN ACT relative to brew pub licenses, relative to insurance cost-sharing calculations, and relative to receipt of pharmaceutical rebates by insurers and pharmacy benefits managers.

 

Be it Enacted by the Senate and House of Representatives in General Court convened:

 

1 New Paragraph; Brew Pub; On-Premise and Off-Premise Licenses. Amend RSA 178:13 by inserting after paragraph XIV the following new paragraph:

XV. Notwithstanding the provisions of RSA 179:11 Holders of Beverage Manufacturer, Wholesale Distributor, Beverage Vendor, and Other Licenses; Prohibited Interests, nothing in that section shall prevent a holder of a brew pub license from holding an on-premises or off-premises license under this chapter, provided that:

(a) The brew pub licensee does not hold any other type of manufacturing license under this title; and

(b) Brew pub licensees holding one or more on-premises or off-premises licenses shall be limited to self- distributing to not more than one on-premises license owned by the brew pub licensee and shall not exceed 2,500 barrels of beer and/or cider during their licensing period. Nothing in this section shall authorize the holder of multiple brewpub licenses to self- distribute to more than one commonly owned on- premises or off- premises license.

2  New Section; Accident and Health Insurance; Fairness in Cost-Sharing Calculations.  Amend RSA 415 by inserting after section 27 the following new section:

415:28  Fairness in Cost-Sharing Calculations.

I.  In this section, "cost-sharing requirements" means any coinsurance, copayment, deductible or out-of-pocket maximum.

II.  When calculating an enrollee's overall contribution to any cost-sharing requirements under an individual or group policy, plan, or contract of accident or health insurance providing benefits for medical or hospital expenses, the insurer or pharmacy benefit manager shall include any amounts paid by the enrollee or paid on behalf of the enrollee.  This requirement shall not apply in the case of a prescription drug for which there is a generic alternative, unless the insured has obtained prior authorization, a step therapy protocol, or the insurer's exceptions and appeals process.  If under federal law, application of this requirement would result in health savings account ineligibility with section 223 of the federal Internal Revenue Code, this requirement shall apply for health savings account-qualified high deductible health plans with respect to the deductible of such a plan after the enrollee has satisfied the minimum deductible under section 223, except for with respect to items or services that are preventive care pursuant to section 223(c)(2)(C) of the federal Internal Revenue Code, in which case the requirements of this paragraph shall apply regardless of whether the minimum deductible under section 223 has been satisfied.

III.  When applying paragraph II to the calculation of an enrollee or insured’s contribution to the annual limitation on cost-sharing set forth in 42 U.S.C. sections 18022(c) and 300gg-6(b), an individual or group policy, plan, or contract of accident or health insurance, or pharmacy benefit manager shall include expenditures for any item or service covered by such insurer or pharmacy benefit manager and included within a category of essential health benefits as described in 42 U.S.C. section 18022(b)(1).

IV.  This section shall apply to a group policy, plan, or contract of accident or health insurance providing benefits for medical or hospital expenses delivered, issued for delivery, or renewed on or after January 1, 2025.

3  New Section; Health Service Corporations; Fairness in Cost-Sharing Calculations.  Amend RSA 420-A by inserting after section 32 the following new section:

420-A:33  Fairness in Cost-Sharing Calculations.

I.  “Cost-sharing requirements" has the same meaning as in RSA 415:28.

II.  Every health service corporation and every similar corporation licensed under the laws of another state that issues or renews any policy, plan, or contract of individual or group accident or health insurance providing benefits for medical or hospital expenses, or pharmacy benefit manager when calculating an enrollee's overall contribution to any cost-sharing requirements shall include any amounts paid by the enrollee or paid on behalf of the enrollee.  This requirement shall not apply in the case of a prescription drug for which there is a generic alternative, unless the insured has obtained prior authorization, a step therapy protocol, or the insurer's exceptions and appeals process.  If under federal law, application of this requirement would result in health savings account ineligibility with section 223 of the federal Internal Revenue Code, this requirement shall apply for health savings account-qualified high deductible health plans with respect to the deductible of such a plan after the enrollee has satisfied the minimum deductible under section 223, except for with respect to items or services that are preventive care pursuant to section 223(c)(2)(C) of the federal Internal Revenue Code, in which case the requirements of this paragraph shall apply regardless of whether the minimum deductible under section 223 has been satisfied.

III.  When applying paragraph II to the calculation of an enrollee or insured’s contribution to the annual limitation on cost-sharing set forth in 42 U.S.C. sections 18022(c) and 300gg-6(b), an individual or group policy, plan, or contract of accident or health insurance, or pharmacy benefit manager shall include expenditures for any item or service covered by such insurer or pharmacy benefit manager and included within a category of essential health benefits as described in 42 U.S.C. section 18022(b)(1).

4  New Section; Health Maintenance Organizations; Fairness in Cost-Sharing Calculations.  Amend RSA 420-B by inserting after section 26 the following new section:

420-B:27  Fairness in Cost-Sharing Calculations.

I.  “Cost-sharing requirements" has the same meaning as in RSA 415:28.

II.  Every health maintenance organization and every similar corporation licensed under the laws of another state that issues or renews any policy, plan, or contract of individual or group health insurance providing benefits for medical or hospital expenses, or pharmacy benefit manager when calculating an enrollee's overall contribution to any cost-sharing requirements shall include any amounts paid by the enrollee or paid on behalf of the enrollee.  This requirement shall not apply in the case of a prescription drug for which there is a generic alternative, unless the insured has obtained prior authorization, a step therapy protocol, or the insurer's exceptions and appeals process.  If under federal law, application of this requirement would result in health savings account ineligibility with section 223 of the federal Internal Revenue Code, this requirement shall apply for health savings account-qualified high deductible health plans with respect to the deductible of such a plan after the enrollee has satisfied the minimum deductible under section 223, except for with respect to items or services that are preventive care pursuant to section 223(c)(2)(C) of the federal Internal Revenue Code, in which case the requirements of this paragraph shall apply regardless of whether the minimum deductible under section 223 has been satisfied.

III.  When applying paragraph II to the calculation of an enrollee or insured’s contribution to the annual limitation on cost-sharing set forth in 42 U.S.C. sections 18022(c) and 300gg-6(b), an individual or group policy, plan, or contract of accident or health insurance, or pharmacy benefit manager shall include expenditures for any item or service covered by such insurer or pharmacy benefit manager and included within a category of essential health benefits as described in 42 U.S.C. section 18022(b)(1).

5  Pharmacy Benefits Manager Reporting.  Amend RSA 402-N:6, I to read as follows:

I.  Each pharmacy benefits manager shall submit an annual or quarterly report to the commissioner containing a list of health benefit plans it administered[,] and the [aggregate amount of all] rebates it collected from pharmaceutical manufacturers that were attributable to patient utilization in the state of New Hampshire during the prior calendar year.  This paragraph shall not apply to Medicaid, the Medicaid Care Management Program, the Ryan White HIV/AIDS Program administered by the department of health and human services, or self-funded plans such as the state employee health benefit plan.  The report submitted to the commissioner shall include the following information:

(a)  The aggregate number of rebates and total value received by the pharmacy benefit manager;

(b)  The aggregate number of rebates and total value distributed to the appropriate health care insurer;

(c)  The aggregate number of rebates and total value passed on to an insured of each health care insurer at the point of sale that reduced the insured’s applicable deductible, copayment, coinsurance, or other cost-sharing amount;

(d)  The individual and aggregate amount paid by the health care insurer to the pharmacy benefit manager for pharmacist services itemized by pharmacy, by product (at the unique NDC level), and by goods and services; and

(e)  The individual and aggregate amount a pharmacy benefit manager paid for pharmacist services itemized by pharmacy, by product, and by goods and services.

6  Pharmaceutical Rebates.  Amend RSA 415-A:7, II-IV to read as follows:

II.  All rebates remitted by or on behalf of a pharmaceutical manufacturer, developer, or labeler, directly or indirectly, to an insurer, or to a pharmacy benefits manager under contract with an insurer, related to its prescription drug benefits shall be remitted in [one or both of] the following ways:

(a)  At least 50 percent of all rebates shall be remitted directly to the covered person at the point of sale to reduce the out-of-pocket cost to the covered person associated with a particular or specific prescription drug;

(b)  Remitted to, and retained by, the insurer.  The remainder of the rebates remitted to the insurer shall be applied by the insurer in its plan design and in future plan years to offset the premium for covered persons.

III.  Beginning [November 1, 2020] March 1, 2025 and annually thereafter, an insurer shall file with the commissioner a report in the manner and form determined by the commissioner demonstrating the manner in which the insurer and/or its contracted entity for pharmacy benefit services has complied with this section. The report shall include at least the following:

(a)  An actuarial certification attesting:

(1)  All discounts and rebates received by health insurers were used to reduce costs for policyholders in compliance with paragraph II .

(2)  How rebates were remitted in the individual, small, and large group market.

(3)  If applied pursuant to subparagraph II(b), an explanation of how remittance was applied to both plan design, based on estimated rebates, and in future plan years to offset premium.

(4)  A description of the methodology employed to calculate the estimated rebate amount, for the purpose of applying to plan design.

(b)  Methodology for determining estimated rebate amount:

(1)  Insurers shall employ actuarial and analytical methodologies to estimate the total rebate amount expected to be received from drug manufacturers over a defined period.

(2)  The determination of the estimated rebate amount shall account for factors such as historical rebate data, anticipated changes in drug utilization, formulary modifications, and other pertinent variables.

(3)  The calculated estimated rebate amount shall adhere to generally accepted actuarial principles and industry best practices to ensure precision and dependability.

(4)  The calculation shall be documented and made available for review by the insurance commissioner, upon request.

III-a.  This section shall not apply to Medicaid, the Medicaid Care Management Program, the Ryan White HIV/AIDS Program administered by the department of health and human services, or self-funded plans such as the state employee health benefit plan.

IV.  Any insurer that violates any provision of this section may, at the discretion of the commissioner, be subject to subparagraph (a) or (b), or both:

(a)  Its certificate of authority may be indefinitely suspended or revoked.

(b)  A civil fine not to exceed [$2,500] $10,000 may be imposed for each violation.  Repeated violations of the same provision shall constitute separate civil offenses.

7  Repeal.  2020; 15:2, relative to the prospective repeal of RSA 415-A:7, is repealed.

8  Effective Date.  

I.  Section 1 of this act shall take effect July 1, 2024.

II.  Section 7 of this act shall take effect June 30, 2024.

III.  The remainder of this act shall take effect 60 days after its passage.

 

LBA

24-2339

Amended 3/29/24

 

HB 1380-FN- FISCAL NOTE

AS AMENDED BY THE HOUSE (AMENDMENT #2024-0872h)

 

AN ACT relative to brew pub licenses.

 

FISCAL IMPACT:      [ X ] State              [    ] County               [    ] Local              [    ] None

 

 

Estimated State Impact - Increase / (Decrease)

 

FY 2024

FY 2025

FY 2026

FY 2027

Revenue

$0

Indeterminable Increase

Indeterminable Increase

Indeterminable Increase

Revenue Fund(s)

Liquor Fund

 

Expenditures

$0

Indeterminable Increase

Indeterminable Increase

Indeterminable Increase

Funding Source(s)

Liquor Fund

 

Appropriations

$0

$0

$0

$0

Funding Source(s)

None

 

Does this bill provide sufficient funding to cover estimated expenditures? [X] N/A

Does this bill authorize new positions to implement this bill? [X] No

 

METHODOLOGY:

The Liquor Commission states this bill would allow a licensed brewpub to hold an additional on-premise or off-premise license as long as the licensee does not hold any other type of manufacturing license.  The bill restricts a licensee holding 2 or more brewpub licenses from selling more than 2,500 barrels of beer or cider to any NH licensed retailer.  The Commission provided the following information and assumptions concerning the fiscal impact of the bill:

 

  • The bill will require the commission to audit licensees holding 2 or more brewpub licenses to ensure compliance with the sales limitation in the bill.  The Commission  anticipates this will increase the number of audits performed by the Commission to ensure compliance with the law.

 

  • Currently there are 33 brewpubs licensed by the Commission.  The Commission is unable to provide an accurate estimate of how many, if any, of the current brewpubs would seek an additional license.

 

  • The Commission assumes it is likely that existing licensees with other license types will switch to the Brew Pub licenses, since they would now be allowed an additional on-premises or off-premises license.  This would result in additional revenue from new licensing fees and additional beer tax revenue.

 

AGENCIES CONTACTED:

Liquor Commission

 

Amendments

Date Amendment
March 18, 2024 2024-0872h
May 8, 2024 2024-1826s
May 23, 2024 2024-2119s

Links


Date Body Type
Jan. 11, 2024 House Hearing
Jan. 11, 2024 House Hearing
March 13, 2024 House Exec Session
March 13, 2024 House Floor Vote
April 30, 2024 Senate Hearing
May 16, 2024 Senate Floor Vote
May 15, 2024 Senate Floor Vote
May 15, 2024 Senate Floor Vote
May 23, 2024 Senate Floor Vote
May 22, 2024 Senate Floor Vote
May 23, 2024 Senate Floor Vote

Bill Text Revisions

HB1380 Revision: 42058 Date: May 25, 2024, 10:26 a.m.
HB1380 Revision: 42436 Date: May 24, 2024, 2:56 p.m.
HB1380 Revision: 42304 Date: May 23, 2024, 1:55 p.m.
HB1380 Revision: 41911 Date: May 8, 2024, 9:09 a.m.
HB1380 Revision: 41460 Date: April 15, 2024, 3:56 p.m.
HB1380 Revision: 41255 Date: March 18, 2024, 3:12 p.m.
HB1380 Revision: 39886 Date: Dec. 6, 2023, 1:33 p.m.

Docket


May 23, 2024: Ought to Pass with Amendment 2024-2119s, MA, VV; OT3rdg; 05/23/2024; SJ 15


May 23, 2024: Sen. Innis Floor Amendment # 2024-2119s, AA, VV; 05/23/2024; SJ 15


May 23, 2024: Special Order to after HB 318, Without Objection, MA; 05/23/2024; SJ 15


May 22, 2024: Special Order to 05/23/2024, Without Objection, MA; 05/22/2024 SJ 14


May 21, 2024: Committee Report: Ought to Pass, 05/22/2024, Vote 6-1; SC 20A


May 15, 2024: Ought to Pass with Amendment 2024-1826s, MA, VV; Refer to Finance Rule 4-5; 05/15/2024; SJ 12


May 15, 2024: Committee Amendment # 2024-1826s, AA, VV; 05/15/2024; SJ 12


May 15, 2024: Special Order to Beginning of Calendar, Without Objection, MA; 05/15/2024; SJ 12


May 15, 2024: Special Order to Beginning of Calendar, Without Objection, MA; 05/15/2024; SJ 12


May 8, 2024: Committee Report: Ought to Pass with Amendment #2024-1826s, 05/16/2024, Vote 4-0; SC 19


April 17, 2024: Hearing: 04/30/2024, Room 100, SH, 10:10 am; SC 16


April 2, 2024: Introduced 03/21/2024 and Referred to Commerce; SJ 8


March 28, 2024: Ought to Pass with Amendment 2024-0872h: MA VV 03/28/2024 HJ 10


March 28, 2024: Amendment # 2024-0872h: AA VV 03/28/2024 HJ 10


March 18, 2024: Committee Report: Ought to Pass with Amendment # 2024-0872h 03/13/2024 (Vote 18-0; CC) HC 12 P. 8


March 7, 2024: Executive Session: 03/13/2024 10:00 am LOB 302-304


Feb. 21, 2024: Subcommittee Work Session: 03/06/2024 10:30 am LOB 302-304


Feb. 14, 2024: Subcommittee Work Session: 02/21/2024 10:00 am LOB 302-304


Feb. 7, 2024: Subcommittee Work Session: 02/13/2024 01:00 pm LOB 306-308


Feb. 7, 2024: Subcommittee Work Session: 02/13/2024 10:00 am LOB 306-308


Feb. 12, 2024: Public Hearing: 01/11/2024 11:00 am LOB 302-304


Jan. 3, 2024: Public Hearing: 01/11/2024 11:00 am LOB 302-304


Dec. 6, 2023: Introduced 01/03/2024 and referred to Commerce and Consumer Affairs HJ 1